4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-22-004151
Options or other derivatives
- Chief Medical Officer acquired 2,581,968 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Norry Elliot Chief Medical Officer | 2022-01-12 | Grant or award · Option to purchase Ordinary Shares | +2,110,608 | 2,110,608 | D | ||
| Norry Elliot Chief Medical Officer | 2022-01-12 | Grant or award · Option to purchase Ordinary Shares | +471,360 | 471,360 | D | ||
Loading xslF345X03/tm221700-6_4seq1.xml…